# Improving Cancer Screening Through A Tailored Technology-Based Intervention

> **NIH NIH R61** · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2021 · $283,016

## Abstract

Cancer is the second leading cause of death in the United States. Health disparities exist in cancer
screening and mortality. Although cancer mortality rates have decreased steadily over the past 25 years, the
racial gap persists, and socioeconomic disparities are widening. Improved early detection and treatment can
decrease cancer mortality, but many barriers exist to screening uptake. Cancer screening is often a trade-off
for both patients and clinicians among different cancer screenings and other preventive opportunities, each of
which have their own barriers to completion. This study seeks to improve quality of care and reduce health
disparities in cancer mortality by using informatics to better tailor clinical discussions in order to enhance
patient motivation to receive screening services and help overcome barriers to screening. The study has the
following aims: 1) to develop a predictive model that identifies patients > 50 years old eligible for lung, breast
and colorectal cancer screening who are at high-risk for missing these screenings; 2) to develop and pilot test
a prototype shared decision-making support tool for patients and clinicians that will increase screening uptake;
3) to perform a pragmatic trial of the refined multilevel intervention that utilizes a shared decision-making
support tool for patients and clinicians.
 During the planning phase, data from the electronic health record (EHR) will be combined with
supplementary data sources (e.g. Area Health Resource File, LexisNexis) to identify patients at risk of not
completing recommended screening for these cancers. Hold-out cross-validation will be used to estimate
model accuracy. Machine learning model building following feature selection will utilize logistic regression and
decision trees to ensure the models are easily transferable to other healthcare settings and interpretable. This
predictive model will be used to develop and pilot test an application that will (A) utilize predictive modeling to
identify eligible patients likely to miss screening; (B) determine, after providing patient education, patient
preferences and concerns regarding screening through self-report augmented by predictive modelling; (C)
identify available community resources to facilitate screening; (D) provide this information to patients and to
clinicians in the EHR prior to clinical visits to assist shared decision-making conversations and support active
problem solving of identified barriers. This multilevel intervention will be pilot-tested and refined within 4
academic primary care practices over 6 months (N=24 clinicians; 8181 potential screenings yearly). A
pragmatic trial will be conducted during the R33 phase using a stepped wedge cluster randomized design
(N=45 clinicians; 11,239 potential screenings yearly). Completed cancer screening will be the primary
outcome. Patient experience, clinician satisfaction and utilization will also be assessed. If successful, this
approach will lead to an in...

## Key facts

- **NIH application ID:** 10238833
- **Project number:** 5R61AG068951-02
- **Recipient organization:** MEDICAL UNIVERSITY OF SOUTH CAROLINA
- **Principal Investigator:** Vanessa Astrud Diaz
- **Activity code:** R61 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $283,016
- **Award type:** 5
- **Project period:** 2020-08-15 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10238833

## Citation

> US National Institutes of Health, RePORTER application 10238833, Improving Cancer Screening Through A Tailored Technology-Based Intervention (5R61AG068951-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10238833. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
